Centessa Pharmaceuticals plc

NasdaqGS:CNTA Stock Report

Market Cap: US$2.2b

Centessa Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:CNTA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Dec 24SellUS$959,057Saurabh SahaIndividual55,000US$17.44
16 Dec 24SellUS$157,256Tia BushIndividual9,611US$16.36
16 Dec 24SellUS$1,175,403Iqbal HussainIndividual71,705US$16.39
20 Nov 24SellUS$928,719Saurabh SahaIndividual55,000US$16.89
25 Oct 24SellUS$180,628Gregory WeinhoffIndividual11,742US$15.38
23 Oct 24SellUS$863,727Saurabh SahaIndividual55,000US$15.80
25 Sep 24SellUS$260,724Gregory WeinhoffIndividual16,619US$15.69

Insider Trading Volume

Insider Buying: CNTA insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of CNTA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies27,5000.0209%
Individual Insiders1,937,3891.47%
General Public10,907,3758.27%
VC/PE Firms39,606,76430%
Institutions79,366,44860.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35%.


Top Shareholders

Top 25 shareholders own 79.78% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.1%
Medicxi Ventures (UK) LLP
19,963,157US$326.4m0%67.82%
7.56%
Index Ventures SA
9,961,789US$162.9m0%7.87%
7.34%
General Atlantic Service Company, L.P.
9,681,818US$158.3m0%3.08%
6.25%
T. Rowe Price Group, Inc.
8,235,044US$134.6m88.7%0.01%
4.76%
Perceptive Advisors LLC
6,282,290US$102.7m59.7%2.5%
4.51%
First Light Asset Management, LLC
5,940,132US$97.1m24.3%9.06%
3.18%
Adage Capital Management, L.P.
4,195,000US$68.6m34.2%0.12%
2.98%
Vida Ventures Advisors, LLC
3,931,818US$64.3m0%42.3%
2.47%
Artal Group S.A.
3,258,677US$53.3m54.3%1.65%
2.45%
EcoR1 Capital, LLC
3,223,851US$52.7m-43.6%1.89%
2.21%
FMR LLC
2,916,494US$47.7m4.64%no data
2.19%
TCG Crossover Management, LLC
2,890,816US$47.3m0%4.43%
2.16%
Point72 Asset Management, L.P.
2,849,783US$46.6m59.4%0.12%
2.13%
Farallon Capital Management, L.L.C.
2,814,318US$46.0m41%0.3%
1.94%
Cormorant Asset Management, LP
2,561,600US$41.9m59%2.35%
1.74%
Franklin Resources, Inc.
2,292,146US$37.5m98.2%0.01%
1.64%
Driehaus Capital Management LLC
2,161,728US$35.3m3.33%0.22%
1.62%
Avidity Partners Management, L.P.
2,132,000US$34.9m0%2.07%
1.53%
Octagon Capital Advisors LP
2,012,052US$32.9m-14.2%5.51%
1.05%
Morgan Stanley, Investment Banking and Brokerage Investments
1,379,151US$22.5m-32.7%no data
1.02%
Commodore Capital LP
1,350,000US$22.1m0%1.62%
1.02%
Deep Track Capital, LP
1,350,000US$22.1m0%0.72%
0.98%
Janus Henderson Group plc
1,294,864US$21.2m0%0.01%
0.97%
5AM Venture Management, LLC
1,285,000US$21.0m3.21%4.83%
0.93%
Baker Bros. Advisors LP
1,227,178US$20.1m123%0.21%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 14:37
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Centessa Pharmaceuticals plc is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullBMO Capital Markets Equity Research
Konstantinos BiliourisBMO Capital Markets Equity Research
Mayank MamtaniB. Riley Securities, Inc.